| [1] |
XIE Mengsheng, ZHAO Yang, CHEN Feng.
Statistical analysis of active extension trial
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(9): 1007-1013.
|
| [2] |
ZHOU Bei, YU Hao.
Optimization of SAE reconciliation in clinical trail
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(4): 428-433.
|
| [3] |
XU Xiaoyan, LIU Yuxiu.
Checkpoint checklist for ADaM submission package and SAS Macros for package validation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(12): 1388-1393.
|
| [4] |
WANG Zeng, YUAN Mei-qin, YANG Guo-nong, DING Hai-ying.
Clinical research progress of ACEI/ARB used in tumor treatment
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(2): 230-234.
|
| [5] |
NI Ping, CHEN Hui, TU Jiao, XU Lin yong.
Assessing the agreement of quantitative data by Bland-Altman method and realizing it with SAS Macro
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(8): 898-903.
|
| [6] |
ZHANG Tao, SUN Ying, LIU Hua-qiang, ZHAO Yan.
Practice and experience to SAS statistical analysis in medical instrument clinical trial
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(3): 326-330.
|
| [7] |
HE Yan, WANG Liang-you.
Inhibitor of thrombin, bivalirudin
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(3): 339-343.
|
| [8] |
HUANG Yao-hua, TANG Xin-ran, WANG Yang, ZHAO Yan-yan, LI Wei.
Application of SAS procedures in evaluation of trough／peak ratio in ambulatory blood pressure monitoring
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(11): 1246-1250.
|
| [9] |
WEN Shi-mei, CHEN Yun-fei, LIU Hua.
SAS programming for sample size and power calculation of measurement data in non-inferior trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(1): 51-54.
|
| [10] |
XU Lin-yong, ZHANG Wei, ZENG Fang, FU Chen-chao, ZHAO Li, ZHAO Xiao-hua, SUN Zhen-qiu.
Auto statistical report for trough/peak ratio index in the evaluation of ambulatory blood pressure monitoring by SAS software
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(7): 798-802.
|
| [11] |
XIE Hai-tang, SUN Hua, LI Juan, TONG Jiu-cui, JIANG Si-yan, LI Hai-gang, PAN Hang-shan, JIA Yuan-wei, SUN Rui-yuan.
Application of covariance analysis in phase Ⅱ clinical trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(11): 1240-1244.
|
| [12] |
XUE Jun, ZHOU Jian-dong, XIONG Ning-ning.
Commonly used SAS macro programs in blind data review of clinical trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(5): 535-540.
|
| [13] |
HU Si-yuan, MA Rong, LIU Xiao-fan, XIANG Xi-xiong, DING Ying, HUANG Wen-yu, HUANG Zhi-jun, XIAO Fei.
Phase Ⅲ clinical trial of Xiaoeryiniao Granule on children with enuresis of kidney-qi deficiency in comparing with meclofenoxate hydrochlorid capsules
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(1): 107-111.
|
| [14] |
BO Qing-yan, XIONG Ning-ning, ZOU Jian-dong, JIANG Meng, LIU Fang, WANG Xiu-qin, GAO Wei-min.
Electronic data capture:achieving the promise of more efficient and higher quality clinical trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(4): 455-459.
|
| [15] |
LI Tao, GUO Lan.
Issues of clinical trails on traditional Chinese new drugs for diabetic poly-neuropathy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(12): 1401-1404.
|
